Figure 2
From: Phase 2 trial of ixazomib in patients with relapsed multiple myeloma not refractory to bortezomib
(a) Waterfall plot of the distribution of depth of the response observed for single agent ixazomib and (b) waterfall plot of the distribution of depth of the response observed across the entire study.
